Barrick mining is more than just a ‘gold play’

The last 50 years have been kind to investors in real terms. Everything made money: equities, bonds, property and gold. All investors had to remember was not to buy high and sell low. But that hasn’t

UK equities are having their time in the sun. The FTSE 100 recently hit an all-time high of 9,000, driven by a broad recovery in equity prices. To put it another way, the rally wasn’t just driven by a

The French personal care powerhouse is a high-quality, cash-generative business with beautiful long-run growth prospects

Companies in the news and how they were assessed

Investors have a lot to think about as the president’s policies gather momentum

In rude health: AstraZeneca, Britain’s biggest drugmaker, has “risen to the challenge” of US healthcare providers negotiating drug prices by posting “solid first-half sales growth”, says Derren Nathan